These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 30782608)

  • 1. FNDC5/Irisin inhibits pathological cardiac hypertrophy.
    Yu Q; Kou W; Xu X; Zhou S; Luan P; Xu X; Li H; Zhuang J; Wang J; Zhao Y; Xu Y; Peng W
    Clin Sci (Lond); 2019 Mar; 133(5):611-627. PubMed ID: 30782608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irisin alleviates pressure overload-induced cardiac hypertrophy by inducing protective autophagy via mTOR-independent activation of the AMPK-ULK1 pathway.
    Li RL; Wu SS; Wu Y; Wang XX; Chen HY; Xin JJ; Li H; Lan J; Xue KY; Li X; Zhuo CL; Cai YY; He JH; Zhang HY; Tang CS; Wang W; Jiang W
    J Mol Cell Cardiol; 2018 Aug; 121():242-255. PubMed ID: 30053525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FNDC5/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin αV/β5-AKT signaling and reduction of oxidative/nitrosative stress.
    Lin C; Guo Y; Xia Y; Li C; Xu X; Qi T; Zhang F; Fan M; Hu G; Zhao H; Zhao H; Liu R; Gao E; Yan W; Tao L
    J Mol Cell Cardiol; 2021 Nov; 160():27-41. PubMed ID: 34224725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.
    Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ
    Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irisin ameliorates high glucose-induced cardiomyocytes injury via AMPK/mTOR signal pathway.
    Deng J; Zhang N; Chen F; Yang C; Ning H; Xiao C; Sun K; Liu Y; Yang M; Hu T; Zhang Z; Jiang W
    Cell Biol Int; 2020 Nov; 44(11):2315-2325. PubMed ID: 32770767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
    Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH
    Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GQ262 Attenuates Pathological Cardiac Remodeling by Downregulating the Akt/mTOR Signaling Pathway.
    Ma H; Ge Y; Di C; Wang X; Qin B; Wang A; Hu W; Lai Z; Xiong X; Qi R
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term activation of adenosine monophosphate-activated protein kinase attenuates pressure-overload-induced cardiac hypertrophy.
    Li HL; Yin R; Chen D; Liu D; Wang D; Yang Q; Dong YG
    J Cell Biochem; 2007 Apr; 100(5):1086-99. PubMed ID: 17266062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sophoricoside ameliorates cardiac hypertrophy by activating AMPK/mTORC1-mediated autophagy.
    Gao M; Hu F; Hu M; Hu Y; Shi H; Zhao GJ; Jian C; Ji YX; Zhang XJ; She ZG; Li H; Zhu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 32964914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium (±)-5-bromo-2-(α-hydroxypentyl) benzoate ameliorates pressure overload-induced cardiac hypertrophy and dysfunction through inhibiting autophagy.
    Wang B; Shen D; Tang J; Li J; Xiao Y; Chen X; Cao C; Han D; Gao E; Zhao W; Zhang J; Chang J
    J Cell Mol Med; 2019 Sep; 23(9):6048-6059. PubMed ID: 31222939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aldolase promotes the development of cardiac hypertrophy by targeting AMPK signaling.
    Li Y; Zhang D; Kong L; Shi H; Tian X; Gao L; Liu Y; Wu L; Du B; Huang Z; Liang C; Wang Z; Yao R; Zhang Y
    Exp Cell Res; 2018 Sep; 370(1):78-86. PubMed ID: 29902536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy.
    Wang Y; Liao H; Wang Y; Zhou J; Wang F; Xie Y; Zhao K; Gao W
    BMC Cardiovasc Disord; 2021 May; 21(1):266. PubMed ID: 34059001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.
    Li DJ; Huang F; Lu WJ; Jiang GJ; Deng YP; Shen FM
    Acta Physiol (Oxf); 2015 Mar; 213(3):711-21. PubMed ID: 25382002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adiponectin deficiency exacerbates cardiac dysfunction following pressure overload through disruption of an AMPK-dependent angiogenic response.
    Shimano M; Ouchi N; Shibata R; Ohashi K; Pimentel DR; Murohara T; Walsh K
    J Mol Cell Cardiol; 2010 Aug; 49(2):210-20. PubMed ID: 20206634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
    Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
    Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Puerarin prevents cardiac hypertrophy induced by pressure overload through activation of autophagy.
    Liu B; Wu Z; Li Y; Ou C; Huang Z; Zhang J; Liu P; Luo C; Chen M
    Biochem Biophys Res Commun; 2015 Aug; 464(3):908-15. PubMed ID: 26188094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exendin-4 attenuates cardiac hypertrophy via AMPK/mTOR signaling pathway activation.
    Zhou Y; He X; Chen Y; Huang Y; Wu L; He J
    Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):394-9. PubMed ID: 26519882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MG53, A Novel Regulator of KChIP2 and I
    Liu W; Wang G; Zhang C; Ding W; Cheng W; Luo Y; Wei C; Liu J
    Circulation; 2019 Apr; 139(18):2142-2156. PubMed ID: 30760025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GPR39 promotes cardiac hypertrophy by regulating the AMPK-mTOR pathway and protein synthesis.
    Liao H; Gao W; Ma J; Xue H; Wang Y; Huang D; Yan F; Ye Y
    Cell Biol Int; 2021 Jun; 45(6):1211-1219. PubMed ID: 33554444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.